These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 23997223

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b+ myeloid cells.
    Arellano G, Acuña E, Loda E, Moore L, Tichauer JE, Castillo C, Vergara F, Burgos PI, Penaloza-MacMaster P, Miller SD, Naves R.
    J Neuroinflammation; 2024 May 31; 21(1):144. PubMed ID: 38822334
    [Abstract] [Full Text] [Related]

  • 5. Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.
    Parekh VV, Wu L, Olivares-Villagómez D, Wilson KT, Van Kaer L.
    J Immunol; 2013 Mar 01; 190(5):1948-60. PubMed ID: 23345328
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome Proliferator-Activated Receptor-δ Acts within Peripheral Myeloid Cells to Limit Th Cell Priming during Experimental Autoimmune Encephalomyelitis.
    Drohomyrecky PC, Doroshenko ER, Akkermann R, Moshkova M, Yi TJ, Zhao FL, Ahn JJ, McGaha TL, Pahan K, Dunn SE.
    J Immunol; 2019 Nov 15; 203(10):2588-2601. PubMed ID: 31578267
    [Abstract] [Full Text] [Related]

  • 7. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S, Périnat T, Greene G, Enzmann G, Deutsch U, Adams R, Imhof B, Aurrand-Lions M, Engelhardt B.
    Brain Behav Immun; 2018 Oct 15; 73():3-20. PubMed ID: 29920328
    [Abstract] [Full Text] [Related]

  • 8. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis.
    Yi H, Guo C, Yu X, Zuo D, Wang XY.
    J Immunol; 2012 Nov 01; 189(9):4295-304. PubMed ID: 23034169
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis.
    Zhu B, Bando Y, Xiao S, Yang K, Anderson AC, Kuchroo VK, Khoury SJ.
    J Immunol; 2007 Oct 15; 179(8):5228-37. PubMed ID: 17911608
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis.
    Saxena N, Won J, Choi S, Singh AK, Singh I.
    Free Radic Biol Med; 2018 Jun 15; 121():57-68. PubMed ID: 29694854
    [Abstract] [Full Text] [Related]

  • 15. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
    Elliott DM, Singh N, Nagarkatti M, Nagarkatti PS.
    Front Immunol; 2018 Jun 15; 9():1782. PubMed ID: 30123217
    [Abstract] [Full Text] [Related]

  • 16. Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
    Ramroodi N, Khani M, Ganjali Z, Javan MR, Sanadgol N, Khalseh R, Ravan H, Sanadgol E, Abdollahi M.
    Immunol Invest; 2015 Jun 15; 44(7):694-712. PubMed ID: 26436854
    [Abstract] [Full Text] [Related]

  • 17. Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments.
    Blidner AG, Salatino M, Mascanfroni ID, Diament MJ, Bal de Kier Joffé E, Jasnis MA, Klein SM, Rabinovich GA.
    J Immunol; 2015 Apr 01; 194(7):3452-62. PubMed ID: 25740944
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier.
    Lee MJ, Bing SJ, Choi J, Jang M, Lee G, Lee H, Chang BS, Jee Y, Lee SJ, Cho IH.
    Mol Neurodegener; 2016 Jul 22; 11(1):54. PubMed ID: 27450563
    [Abstract] [Full Text] [Related]

  • 20. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
    Jung S, Toyka K, Hartung HP.
    Eur J Immunol; 1995 May 22; 25(5):1391-8. PubMed ID: 7539758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.